共 16 条
- [4] Applying the New Classification Criteria for Rheumatoid Arthritis to Patients (pts) with Early Rheumatoid Arthritis Treated with Abatacept Plus MTX-Insights From AGREE (Abatacept study to Gauge Remission and joint damage progression in MTX naive patients with Early Erosive Rheumatoid Arthritis). [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S614 - S614
- [5] Adalimumab with Methotrexate in Treatment-Naïve Japanese Patients with Rheumatoid Arthritis at Risk of Progressive Structural Joint Damage: A Postmarketing Observational Study [J]. Rheumatology and Therapy, 2017, 4 : 151 - 166
- [7] Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE) [J]. ARTHRITIS RESEARCH & THERAPY, 2015, 17
- [8] Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE) [J]. Arthritis Research & Therapy, 17